JD Health International Future Growth
Future criteria checks 3/6
JD Health International is forecast to grow earnings and revenue by 15.7% and 10.6% per annum respectively. EPS is expected to grow by 15.2% per annum. Return on equity is forecast to be 7.8% in 3 years.
Key information
15.7%
Earnings growth rate
15.2%
EPS growth rate
Consumer Retailing earnings growth | 28.0% |
Revenue growth rate | 10.6% |
Future return on equity | 7.8% |
Analyst coverage | Good |
Last updated | 27 Aug 2024 |
Recent future growth updates
Recent updates
A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Sep 05Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence
Aug 08Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price
Jul 21This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends
Dec 07What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?
Nov 20JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 02Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital
Aug 21JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price
Aug 03JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues
Jun 08Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?
Apr 19Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
Dec 29Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?
Sep 14A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Dec 04Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Mar 08Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 72,588 | 4,162 | 7,543 | 7,446 | 16 |
12/31/2025 | 65,222 | 3,612 | 6,242 | 5,547 | 19 |
12/31/2024 | 57,821 | 3,127 | 4,209 | 4,509 | 19 |
6/30/2024 | 54,764 | 2,618 | 6,406 | 6,467 | N/A |
3/31/2024 | 54,147 | 2,380 | 5,475 | 5,536 | N/A |
12/31/2023 | 53,530 | 2,142 | 4,544 | 4,605 | N/A |
9/30/2023 | 53,576 | 1,930 | 3,135 | 4,311 | N/A |
6/30/2023 | 53,621 | 1,718 | 1,726 | 4,017 | N/A |
3/31/2023 | 50,179 | 1,049 | 2,679 | 4,961 | N/A |
12/31/2022 | 46,736 | 380 | 3,632 | 5,905 | N/A |
9/30/2022 | 42,003 | -7 | 3,440 | 4,829 | N/A |
6/30/2022 | 37,270 | -395 | 3,249 | 3,753 | N/A |
3/31/2022 | 33,976 | -734 | 3,085 | 3,592 | N/A |
12/31/2021 | 30,682 | -1,074 | 2,921 | 3,431 | N/A |
9/30/2021 | 27,463 | -6,702 | 4,068 | 4,352 | N/A |
6/30/2021 | 24,243 | -12,331 | 5,216 | 5,274 | N/A |
3/31/2021 | 21,813 | -14,783 | 4,439 | 4,487 | N/A |
12/31/2020 | 19,383 | -17,234 | 3,662 | 3,699 | N/A |
9/30/2020 | 17,007 | -11,901 | 1,980 | 2,004 | N/A |
6/30/2020 | 14,631 | -6,567 | 298 | 309 | N/A |
3/31/2020 | 12,737 | -3,769 | 351 | 359 | N/A |
12/31/2019 | 10,842 | -972 | 404 | 409 | N/A |
12/31/2018 | 8,169 | 215 | 185 | 187 | N/A |
12/31/2017 | 5,553 | 179 | N/A | 36 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6618's forecast earnings growth (15.7% per year) is above the savings rate (2.3%).
Earnings vs Market: 6618's earnings (15.7% per year) are forecast to grow faster than the Hong Kong market (12% per year).
High Growth Earnings: 6618's earnings are forecast to grow, but not significantly.
Revenue vs Market: 6618's revenue (10.6% per year) is forecast to grow faster than the Hong Kong market (7.6% per year).
High Growth Revenue: 6618's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6618's Return on Equity is forecast to be low in 3 years time (7.8%).